The pharmaceutical sector has come under parliamentary scrutiny, with growing concerns over the safety of medicines in Namibia and the regulation of local manufacturers. 

The Central Procurement Board of Namibia (CPBN) has refuted allegations that it corruptly awarded an unadvertised multimillion-dollar tender to a local pharmaceutical company, Fabupharm.